šŸ§  Parkinson's Digest Give Feedback
  • All
  • Research
  • Trials
  • News
Post-marketing safety concerns with foscarbidopa/foslevodopa: A pharmacovigilance study with disproportionality analysis based on FAERS.
Research Medicine None
Developing and validating a clinically actionable prediction tool for Parkinson disease using explainable machine learning with multidimensional national data: A cross-sectional study.
Research Medicine None
Glycated haemoglobin (HbA1c) levels and motor symptoms in Parkinson's disease.
Research The Indian journal of medical research None
Foslevodopa+foscarbidopa for advanced Parkinson disease.
Research Australian prescriber None
Dietary oneā€‘carbon nutrients and genetic risk in Parkinson disease: a prospective cohort study.
Research The journals of gerontology. Series A, Biological sciences and medical sciences None
Previous

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Feedback | Privacy Policy | Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

Ā© 2026 Parkinson's Digest